Sagittarius Life Science Corp (3205.TWO)
TWD 27.55
(-9.97%)
TWD 27.55
(-9.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 664.72 Million TWD | 14.78% |
| 2022 | 579.12 Million TWD | -14.3% |
| 2021 | 675.74 Million TWD | -8.77% |
| 2020 | 740.74 Million TWD | -8.73% |
| 2019 | 811.59 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 619.53 Million TWD | -6.8% |
| 2024 Q2 | 635.17 Million TWD | 2.52% |
| 2023 Q3 | 607.61 Million TWD | 11.88% |
| 2023 FY | 664.72 Million TWD | 14.78% |
| 2023 Q1 | 546.88 Million TWD | 0.0% |
| 2023 Q2 | 543.11 Million TWD | -0.69% |
| 2023 Q4 | 664.72 Million TWD | 9.4% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -419.124% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 77.086% |
| Level Biotechnology Inc. | 822.67 Million TWD | 19.2% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -21.134% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 82.929% |
| GlycoNex Incorporation | 1.55 Billion TWD | 57.192% |
| VBI | 452.1 Million TWD | -47.029% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 43.483% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 11.201% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -75.684% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 41.374% |
| Visgeneer Inc. | 397.17 Million TWD | -67.362% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 82.37% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 69.212% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 24.728% |
| Neith Corporation | 192.15 Million TWD | -245.934% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 89.09% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -803.672% |
| Enimmune corporation | 604.82 Million TWD | -9.903% |
| TaiRx, Inc. | 833.74 Million TWD | 20.273% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 78.46% |
| EirGenix Inc. | 11.16 Billion TWD | 94.045% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -15.979% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 61.181% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 81.519% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 36.722% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -120.815% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -151.164% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -50.666% |
| RBC Bioscience Corporation | 753.79 Million TWD | 11.816% |
| BiOptic Inc. | 613.77 Million TWD | -8.301% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 62.628% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 42.682% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -3.082% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 78.6% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -349.338% |
| NaviFUS Corp. | 490.53 Million TWD | -35.51% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 45.769% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 51.244% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -25.622% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 42.765% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 59.866% |
| AP Biosciences Inc | 890.75 Million TWD | 25.375% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 92.205% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -105.068% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 50.157% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 75.481% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 95.673% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -62.026% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -67.499% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 67.979% |
| TCI GENE Inc. | 1.16 Billion TWD | 42.988% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -125.65% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 51.243% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 29.417% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 4.829% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 83.188% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 82.611% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 45.95% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 88.138% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 37.409% |
| Acepodia, Inc. | 6.81 Billion TWD | 90.251% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 82.628% |